Click for best price
Hematuria Treatment Market Size, Share 2024
Hematuria is a medical condition indicated by the presence of blood in the urine; under normal circumstances, urine does not contain RBCs. This can result in serious issue that may also cause kidney stones, urinary tract infection, and other inherited diseases. The hematuria treatment market, based on treatment, is segmented into drugs, therapies, and others. As hematuria is associated with various indications such as the UTI, kidney stone, blood cancer, bladder stones, and prostate cancer, the drugs used for these indications can also be used for its treatment. Alfuzosin, ciprofloxacin, doxazosin, ibuprofen, and tamsulosin are among the commonly used drugs for the hematuria treatment. This is a preferred treatment type as the drugs can be administered at home and in healthcare settings.
This report aims to provide a comprehensive presentation of the global market for Hematuria Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematuria Treatment. This report contains market size and forecasts of Hematuria Treatment in global, including the following market information:
Global Hematuria Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Hematuria Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Macroscopic Hematuria Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hematuria Treatment include AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc. and Sun Pharmaceutical Industries Ltd, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hematuria Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematuria Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Hematuria Treatment Market Segment Percentages, by Type, 2023 (%)
Macroscopic Hematuria
Microscopic Hematuria
Idiopathic Hematuria
Jogger?s Hematuria
Global Hematuria Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Hematuria Treatment Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Others
Global Hematuria Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Hematuria Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematuria Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Hematuria Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Bristol-Myers Squibb Company
F. HOFFMANN-LA ROCHE LTD.
GlaxoSmithKline plc.
Janssen Pharmaceuticals
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematuria Treatment, market overview.
Chapter 2: Global Hematuria Treatment market size in revenue.
Chapter 3: Detailed analysis of Hematuria Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematuria Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hematuria Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hematuria Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematuria Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematuria Treatment Overall Market Size
2.1 Global Hematuria Treatment Market Size: 2023 VS 2030
2.2 Global Hematuria Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematuria Treatment Players in Global Market
3.2 Top Global Hematuria Treatment Companies Ranked by Revenue
3.3 Global Hematuria Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hematuria Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hematuria Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematuria Treatment Players in Global Market
3.6.1 List of Global Tier 1 Hematuria Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Hematuria Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hematuria Treatment Market Size Markets, 2023 & 2030
4.1.2 Macroscopic Hematuria
4.1.3 Microscopic Hematuria
4.1.4 Idiopathic Hematuria
4.1.5 Jogger?s Hematuria
4.2 By Type - Global Hematuria Treatment Revenue & Forecasts
4.2.1 By Type - Global Hematuria Treatment Revenue, 2019-2024
4.2.2 By Type - Global Hematuria Treatment Revenue, 2025-2030
4.2.3 By Type - Global Hematuria Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hematuria Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Hematuria Treatment Revenue & Forecasts
5.2.1 By Application - Global Hematuria Treatment Revenue, 2019-2024
5.2.2 By Application - Global Hematuria Treatment Revenue, 2025-2030
5.2.3 By Application - Global Hematuria Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hematuria Treatment Market Size, 2023 & 2030
6.2 By Region - Global Hematuria Treatment Revenue & Forecasts
6.2.1 By Region - Global Hematuria Treatment Revenue, 2019-2024
6.2.2 By Region - Global Hematuria Treatment Revenue, 2025-2030
6.2.3 By Region - Global Hematuria Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hematuria Treatment Revenue, 2019-2030
6.3.2 US Hematuria Treatment Market Size, 2019-2030
6.3.3 Canada Hematuria Treatment Market Size, 2019-2030
6.3.4 Mexico Hematuria Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hematuria Treatment Revenue, 2019-2030
6.4.2 Germany Hematuria Treatment Market Size, 2019-2030
6.4.3 France Hematuria Treatment Market Size, 2019-2030
6.4.4 U.K. Hematuria Treatment Market Size, 2019-2030
6.4.5 Italy Hematuria Treatment Market Size, 2019-2030
6.4.6 Russia Hematuria Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Hematuria Treatment Market Size, 2019-2030
6.4.8 Benelux Hematuria Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hematuria Treatment Revenue, 2019-2030
6.5.2 China Hematuria Treatment Market Size, 2019-2030
6.5.3 Japan Hematuria Treatment Market Size, 2019-2030
6.5.4 South Korea Hematuria Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Hematuria Treatment Market Size, 2019-2030
6.5.6 India Hematuria Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hematuria Treatment Revenue, 2019-2030
6.6.2 Brazil Hematuria Treatment Market Size, 2019-2030
6.6.3 Argentina Hematuria Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hematuria Treatment Revenue, 2019-2030
6.7.2 Turkey Hematuria Treatment Market Size, 2019-2030
6.7.3 Israel Hematuria Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Hematuria Treatment Market Size, 2019-2030
6.7.5 UAE Hematuria Treatment Market Size, 2019-2030
7 Hematuria Treatment Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Hematuria Treatment Major Product Offerings
7.1.4 AstraZeneca Hematuria Treatment Revenue in Global Market (2019-2024)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Hematuria Treatment Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Hematuria Treatment Revenue in Global Market (2019-2024)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 F. HOFFMANN-LA ROCHE LTD.
7.3.1 F. HOFFMANN-LA ROCHE LTD. Company Summary
7.3.2 F. HOFFMANN-LA ROCHE LTD. Business Overview
7.3.3 F. HOFFMANN-LA ROCHE LTD. Hematuria Treatment Major Product Offerings
7.3.4 F. HOFFMANN-LA ROCHE LTD. Hematuria Treatment Revenue in Global Market (2019-2024)
7.3.5 F. HOFFMANN-LA ROCHE LTD. Key News & Latest Developments
7.4 GlaxoSmithKline plc.
7.4.1 GlaxoSmithKline plc. Company Summary
7.4.2 GlaxoSmithKline plc. Business Overview
7.4.3 GlaxoSmithKline plc. Hematuria Treatment Major Product Offerings
7.4.4 GlaxoSmithKline plc. Hematuria Treatment Revenue in Global Market (2019-2024)
7.4.5 GlaxoSmithKline plc. Key News & Latest Developments
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Summary
7.5.2 Janssen Pharmaceuticals Business Overview
7.5.3 Janssen Pharmaceuticals Hematuria Treatment Major Product Offerings
7.5.4 Janssen Pharmaceuticals Hematuria Treatment Revenue in Global Market (2019-2024)
7.5.5 Janssen Pharmaceuticals Key News & Latest Developments
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Company Summary
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Hematuria Treatment Major Product Offerings
7.6.4 Merck & Co., Inc. Hematuria Treatment Revenue in Global Market (2019-2024)
7.6.5 Merck & Co., Inc. Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Hematuria Treatment Major Product Offerings
7.7.4 Novartis AG Hematuria Treatment Revenue in Global Market (2019-2024)
7.7.5 Novartis AG Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Hematuria Treatment Major Product Offerings
7.8.4 Pfizer Inc. Hematuria Treatment Revenue in Global Market (2019-2024)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 Sun Pharmaceutical Industries Ltd
7.9.1 Sun Pharmaceutical Industries Ltd Company Summary
7.9.2 Sun Pharmaceutical Industries Ltd Business Overview
7.9.3 Sun Pharmaceutical Industries Ltd Hematuria Treatment Major Product Offerings
7.9.4 Sun Pharmaceutical Industries Ltd Hematuria Treatment Revenue in Global Market (2019-2024)
7.9.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.10 Boehringer Ingelheim International GmbH
7.10.1 Boehringer Ingelheim International GmbH Company Summary
7.10.2 Boehringer Ingelheim International GmbH Business Overview
7.10.3 Boehringer Ingelheim International GmbH Hematuria Treatment Major Product Offerings
7.10.4 Boehringer Ingelheim International GmbH Hematuria Treatment Revenue in Global Market (2019-2024)
7.10.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hematuria Treatment Market Opportunities & Trends in Global Market
Table 2. Hematuria Treatment Market Drivers in Global Market
Table 3. Hematuria Treatment Market Restraints in Global Market
Table 4. Key Players of Hematuria Treatment in Global Market
Table 5. Top Hematuria Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hematuria Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hematuria Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hematuria Treatment Product Type
Table 9. List of Global Tier 1 Hematuria Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hematuria Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hematuria Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hematuria Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hematuria Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hematuria Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hematuria Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hematuria Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hematuria Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hematuria Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hematuria Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hematuria Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hematuria Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hematuria Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hematuria Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hematuria Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hematuria Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hematuria Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hematuria Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hematuria Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hematuria Treatment Revenue, (US$, Mn), 2025-2030
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Hematuria Treatment Product Offerings
Table 32. AstraZeneca Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Company Summary
Table 35. Bristol-Myers Squibb Company Hematuria Treatment Product Offerings
Table 36. Bristol-Myers Squibb Company Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Bristol-Myers Squibb Company Key News & Latest Developments
Table 38. F. HOFFMANN-LA ROCHE LTD. Company Summary
Table 39. F. HOFFMANN-LA ROCHE LTD. Hematuria Treatment Product Offerings
Table 40. F. HOFFMANN-LA ROCHE LTD. Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. F. HOFFMANN-LA ROCHE LTD. Key News & Latest Developments
Table 42. GlaxoSmithKline plc. Company Summary
Table 43. GlaxoSmithKline plc. Hematuria Treatment Product Offerings
Table 44. GlaxoSmithKline plc. Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. GlaxoSmithKline plc. Key News & Latest Developments
Table 46. Janssen Pharmaceuticals Company Summary
Table 47. Janssen Pharmaceuticals Hematuria Treatment Product Offerings
Table 48. Janssen Pharmaceuticals Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Janssen Pharmaceuticals Key News & Latest Developments
Table 50. Merck & Co., Inc. Company Summary
Table 51. Merck & Co., Inc. Hematuria Treatment Product Offerings
Table 52. Merck & Co., Inc. Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Merck & Co., Inc. Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Hematuria Treatment Product Offerings
Table 56. Novartis AG Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Pfizer Inc. Company Summary
Table 59. Pfizer Inc. Hematuria Treatment Product Offerings
Table 60. Pfizer Inc. Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Pfizer Inc. Key News & Latest Developments
Table 62. Sun Pharmaceutical Industries Ltd Company Summary
Table 63. Sun Pharmaceutical Industries Ltd Hematuria Treatment Product Offerings
Table 64. Sun Pharmaceutical Industries Ltd Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 66. Boehringer Ingelheim International GmbH Company Summary
Table 67. Boehringer Ingelheim International GmbH Hematuria Treatment Product Offerings
Table 68. Boehringer Ingelheim International GmbH Hematuria Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Boehringer Ingelheim International GmbH Key News & Latest Developments
List of Figures
Figure 1. Hematuria Treatment Segment by Type in 2023
Figure 2. Hematuria Treatment Segment by Application in 2023
Figure 3. Global Hematuria Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hematuria Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hematuria Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hematuria Treatment Revenue in 2023
Figure 8. By Type - Global Hematuria Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hematuria Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hematuria Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hematuria Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hematuria Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hematuria Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hematuria Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hematuria Treatment Revenue Market Share, 2019-2030
Figure 16. US Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hematuria Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hematuria Treatment Revenue Market Share, 2019-2030
Figure 28. China Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hematuria Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hematuria Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hematuria Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. AstraZeneca Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bristol-Myers Squibb Company Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. F. HOFFMANN-LA ROCHE LTD. Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. GlaxoSmithKline plc. Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Janssen Pharmaceuticals Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Merck & Co., Inc. Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Novartis AG Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pfizer Inc. Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sun Pharmaceutical Industries Ltd Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Boehringer Ingelheim International GmbH Hematuria Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
